Katherine D. Adams
FDA investigator
Appears on 2 documents from 2017 to 2019, mostly at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).
- 2
- Documents on file
- 7.0
- Observations per 483
- 2017
- First seen
- 2019
- Most recent
What they cite most
From 14 observations- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.160General requirements2
- 21 CFR 211.192Production record review2
- 21 CFR 211.170Reserve samples1
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.22Responsibilities of quality control unit1
Activity by year
2017: 1, 2019: 1
Where
India 1 · Malaysia 1
Often inspects with
Is Katherine D. Adams coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2019-07-05 | 483 Form 483 · FEI 3011248248Jul 5, 2019 · Iskander Puteri, Malaysia | Iskander Puteri, Malaysia | 12 | |
| 2017-02-03 | 483 GLAND PHARMA LIMITEDFeb 3, 2017 · Hyderabad, India | Hyderabad, India | 2 |
About this profile
What does Katherine D. Adams inspect?
Katherine D. Adams appears on 2 documents on file covering 2 sites, mostly in India.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.160 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Katherine D. Adams is dated Jul 5, 2019.